Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
03/2005
03/17/2005WO2005023177A2 Human monoclonal antibodies against bacillusanthracis protective antigen
03/17/2005WO2005023091A2 Method for non-invasive prenatal diagnosis
03/17/2005WO2005023083A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
03/17/2005WO2004111217A3 Variant pseudomonas polypeptides having a non-maltogenic exoamylase activity and their use in preparing food products
03/17/2005WO2004106488A3 Gene expression suppression agents
03/17/2005WO2004092399A3 Real-time polmerase chain reaction-based genotyping assay for single nucleotide polymorphism
03/17/2005WO2004044177A3 Expression profiling based on histocultures
03/17/2005WO2004010767A3 Application of aspen mads-box genes to alter reproduction and development in trees
03/17/2005WO2003089899A3 Probes for detecting tumor cells
03/17/2005US20050059815 Processes for the synthesis of 2'-O-substituted pyrimidines and oligomeric compounds therefrom
03/17/2005US20050059808 Mixture comprising type I transmembrane protein with immunoglobulin like extracellular domain for use as tool in identifying modulator which control development, differentiation and/or physiology of mammalian immune system
03/17/2005US20050059804 Porcine alpha2delta-1 calcium channel submit cDNA and soluble secreted alpha2delta-1 subunit polypeptides
03/17/2005US20050059625 Immunostimulatory nucleic acid molecules
03/17/2005US20050059619 Immunostimulatory nucleic acids
03/17/2005US20050059617 Novel anitsense oligonucleotide derivatives against to hepatitis c virus
03/17/2005US20050059128 Heme domain modified cytochrome p450 monooxygenase for use in hydroxylating linear alkanes using atmospheric dioxygen as an oxidant
03/17/2005US20050059126 Engineered enzymes comprised of protein scaffold and specificity determining regions; fusion proteins, nucleic acid molecules, vectors, host cells
03/17/2005US20050059117 Nucleotide sequences coding endothelial growth factor for use as tools in treatment and prevention of cell prolifreative disorders; antitumor agents
03/17/2005US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders
03/17/2005US20050059094 Electrophysiological assay using oocytes that express human ENaC and the use phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes
03/17/2005US20050059088 Alternatively spliced isoforms of receptor-interacting serine-threonine kinase 2 (RIPK2)
03/17/2005US20050059069 Stable hybrid
03/17/2005US20050059066 Nucleosides; enhanced binding affinity and nuclease resistance; gene expression inhibition
03/17/2005US20050059060 Oligonucleotide for use as gene trapped sequences (GTSs) and tools in detection and recovery of novel genes; genetic engineering and gene expression analysis; genomics; forensic analysis
03/17/2005US20050059056 Antigenic gp100 (154-162) compounds for therapy and diagnosis and methods for using same
03/17/2005US20050059053 Generating plants comprising polypeptides with enhanced properties; directed evolution of proteins; bioreactor and heterologous gene expression
03/17/2005US20050059052 Ire1p, novel mammalian protein, and gene encoding same
03/17/2005US20050059049 Oligonucleotide sequences comprising single-stranded target-binding segment and regions of dyad symmetry for use diagnostic tools in genomic analysis
03/17/2005US20050059047 Expression vector comprising nucleotide sequences coding 26S protease regulatory subunit 8 (SUG-1) for use tool to enhance transcription of heterologous sequences in transgenic plants
03/17/2005US20050059044 Small interfering RNA sequences for use as gene silencing tools; gene expression inhibition
03/17/2005US20050059041 Nucleic acids arrays and methods of use therefor
03/17/2005US20050059037 Undergoing a change in the fluorescent signal intensity depending on the corresponding base type in the partner strand with which the single-stranded sequence is hybridized
03/17/2005US20050059035 Nucleotide sequences coding cystic fibrosis transmembrane conductance regulator (CFTR) protein for use in diagnosis prevention and treatment of respiratory system, pulmonary and pancreatic disorders
03/17/2005US20050059028 RNAi-based sensors, caged interfering RNAs, and methods of use thereof
03/17/2005US20050059018 Virulence-associated nucleic acids and proteins and uses thereof
03/17/2005US20050059016 Structural motifs and oligomeric compounds and their use in gene modulation
03/17/2005US20050059015 A nucleotide sequence and a complement used to screen, diagnose and monitor individuals for obesity and/or diabetes by detecting the presence, absence, or quantity of a translation product of a transcript having a sequence selected from the group of amino acid sequences; antidiabetic agents
03/17/2005US20050059013 Use of biomarkers for detecting ovarian cancer
03/17/2005US20050059012 Using human epithelial membrane protein 1 sequences as diagnostic tool in detection cell proliferative disorders and antitumor resistant genic variation
03/17/2005US20050058998 Amino acid and nucleic acid sequences of cyclic nucleotide phosphodiesterases that are involved in T cell activation and may be used in the diagnosis and treatment of disorders such as autoimmune diseases
03/17/2005US20050058995 Primers for use in detecting beta-lactamases
03/17/2005US20050058747 For use in animal feed, in particular fish feed, and detergents
03/17/2005US20050058662 Novel type III secretion pathway in Aeromonas salmonicida, and uses therefor
03/17/2005US20050058661 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia
03/17/2005US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases
03/17/2005CA2538270A1 Primers for use in detecting beta-lactamases
03/17/2005CA2538174A1 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
03/17/2005CA2537881A1 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene
03/17/2005CA2537273A1 Method for the production of fusion proteins in transgenic mammal milk
03/17/2005CA2537254A1 Methods for identifying, diagnosing, and predicting survival of lymphomas
03/17/2005CA2536015A1 Modified oligonucleotides for telomerase inhibition
03/17/2005CA2526398A1 Human monoclonal antibodies against bacillus anthracis protective antigen
03/16/2005EP1514934A2 Biosynthetic binding protein for cancer marker
03/16/2005EP1514929A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells
03/16/2005EP1513937A2 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein
03/16/2005EP1513936A2 Use of repression blocking sequences in methods for enhancing gene expression
03/16/2005EP1513859A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
03/16/2005EP1513482A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
03/16/2005EP1513402A1 Improved inhibitors of adp-ribosyl transferases, cyclases, and hydrolases
03/16/2005EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides
03/16/2005CN1596267A Genes coding for regulatory proteins
03/16/2005CN1594588A Feature sequence amplification mark closely interlocked with Chinese cabbage tangerine core character and obtaining method thereof
03/16/2005CN1594568A Method for preparing recombinant chicken alpha-interferon and its recombinant vector
03/16/2005CN1594563A Differential expression gene for rice and method for preparing same
03/16/2005CN1594562A Method for separating and purifying superhelix plasmid and application thereof
03/16/2005CN1594348A T cell receptor sequence and method for detecting and treating rheumatoid arthritis
03/16/2005CN1594347A Gene therapeutic drug hdm2-siRNA for breast cancer
03/16/2005CN1193041C New human protein with the function of inhibiting cancer cell growth and its encoding sequence
03/16/2005CN1193040C New human protein with the function of inhibiting tumor cell growth and its encoding sequence
03/15/2005US6867294 Design and synthesis of nuclease resistant gapped oligonucleotides which are useful for therapeutics, diagnostics and as research reagents ; are also capable of modulating the activity of DNA and RNA
03/15/2005US6867291 Human hemicentin proteins and polynucleotides encoding the same
03/15/2005US6867290 Nucleotide sequences for use as tools in human therapeutics and diagnostics
03/15/2005US6867289 Thio-modified aptamer synthetic methods and compositions
03/15/2005US6867199 Clearing retained mucous secretions, balancing tissue hydration and fluid secretion, and/or inhibiting or preventing early stages of platelet activation, degranulation and aggregation
03/15/2005US6867039 Oligonucleotides, specifically hybridizable with nucleic acids encoding dual specific phosphatase 5
03/15/2005US6867020 Nucleotide sequences coding preferential polypeptides associated with blood formation; for use in treatment of blood disorders
03/15/2005US6867017 ATP-binding transporter (ABC7) and methods for detection of anemia and ataxia
03/15/2005US6867013 Methods of screening for antagonists and agonists of polypeptides having kinase functions
03/15/2005US6866827 Using device having four inserts each with n reaction vessels (n >= 1) arranged on or in a plate each insert in its own station, with each reaction vessel containing initiator base bound to an inert carrier; time saving
03/10/2005WO2005021803A1 Improved bisulfite method employing size exclusion step
03/10/2005WO2005021802A2 Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil
03/10/2005WO2005021778A2 Method and materials for polyamine catalyzed bisulfite conversion of cytosine to uracil
03/10/2005WO2005021758A1 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
03/10/2005WO2005021727A2 Isoform-specific targeting of splice variants
03/10/2005WO2005021725A2 Nucleic acid analysis method conducted in small reaction volumes
03/10/2005WO2005021723A2 Nucleic acid molecules from rice controlling abiotic stress tolerance
03/10/2005WO2005021718A2 Tubulin regulatory elements for use in plants
03/10/2005WO2005021592A2 Enhancing the circulating half-life of interleukin-2 proteins
03/10/2005WO2005021585A2 Axmi-003, a delta-endotoxin gene and methods for its use
03/10/2005WO2005021577A2 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof
03/10/2005WO2005021572A1 Ptp1b antisense compound
03/10/2005WO2005021570A1 Novel artificial nucleic acids of n-o bond crosslinkage type
03/10/2005WO2005021563A2 Method and materials for bisulfite conversion of cytosine to uracil
03/10/2005WO2005021044A2 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
03/10/2005WO2005020934A2 Fsh glycosylation mutant
03/10/2005WO2005020890A2 Multiplexed molecular beacon assay for detection of pathogens
03/10/2005WO2005020889A2 Functional influenza virus-like particles (vlps)
03/10/2005WO2005020794A2 Taxane chemosensitivity prediction test
03/10/2005WO2005007823A3 Compositions, kits, and methods for stimulation of homologous recombination
03/10/2005WO2005007815A3 Hairpin-labeled probes and methods of use